ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2018 American Transplant Congress

    Presentation and Outcomes of Post-Transplant Proliferative Disorder at a Single Institution Pediatric Transplant Center

    G. Ramos-Gonzalez,1 A. Allain,1 T. Agur,1 L. O'Melia,1 S. Staffa,2 S. Burchett,1 B. Siegele,3 O. Weinberg,3 N. Rodig,1 R. Fawaz,1 T. Singh,1 D. Freiberger,1 K. Heung Bae.1

    1Pediatric Transplant Center, Boston Children's Hospital, Boston, MA; 2Department of Surgery, Boston Children's Hospital, Boston, MA; 3Department of Pathology, Boston Children's Hospital, Boston, MA.

    Purpose: The aim of this study was to characterize features present at the time of post-transplant lymphoproliferative disorder (PTLD) diagnosis, as well as outcomes, following…
  • 2018 American Transplant Congress

    Ex-Vivo Subnormothermic Oxygenated Machine Perfusion of Rodent Hindlimb: Feasibility Study to Elongate Preservation Time of Vascularized Composite Allograft

    L. Burlage,1,2 A. Lellouch,3,4 S. Tessier,1 C. Pendexter,1 S. Cronin,1 M. Schol,3 M. Randolph,3 R. Porte,2 L. Lantieri,4 C. Cetrulo,3 K. Uygun.1

    1Surgery, Massachusetts General Hospital/Harvard Medical School, Boston; 2Surgery, University Medical Center Groningen, Groningen, Netherlands; 3Plastic Surgery, Massachusetts General Hospital/Harvard Medical School, Boston; 4Plastic Surgery, European George Pompidou Hospital, Paris, France.

    PURPOSE: A pressing challenge in the field of VCA is adequate tissue preservation. Static cold preservation, successfully used in field of solid organ transplantation, greatly…
  • 2018 American Transplant Congress

    Correlation of Kidney Transplant Human Leukocyte Antigen Eplet Mismatching to De Novo Donor Specific Antibody Production and Post-Transplant Outcomes

    R. Samudralwar,1 K. Szempruch,1 C. Reuter,3 B. Franz,4 R. Lee,1 E. Weimer,4 R. Detwiler,2 T. Kozlowski,2 J. Schmitz.4

    1Department of Pharmacy, Universitty of North Carolina Medical Center, Chapel Hill, NC; 2Department of Surgery, Universitty of North Carolina Medical Center, Chapel Hill, NC; 3Department of Pharmacy, Ochsner Health System, New Orleans, LA; 4Department of Pathology, University of North Carolina Medical Center, Chapel Hill, NC.

    Human Leukocyte Antigen (HLA) eplet mismatches (EMM) are associated with the development of de novo donor specific antibody (dnDSA) in kidney transplant recipients (KTRs). There…
  • 2018 American Transplant Congress

    FSGS Pattern with Podocyte Proliferation and Heavy Proteinuria Combined Late Antibody Mediated Rejection of Renal Allograft: Collapsing Glomerulopathy or Transplant Podocytopathy?

    J. Wen, M. Zhang, F. Xu, J. Chen, D. Cheng, X. Ni, X. Li.

    National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China.

    Background: Collapsing Glomerulopathy is a pathologically and clinically distinct variant of FSGS with poor prognosis.Hemodynamic disturbances may play a role in the development of the…
  • 2018 American Transplant Congress

    Machine Learning to Assess Kidney Donor Risk

    A. Shah, M. Li, Z. Chen.

    Thomas Jefferson University, Philadelphia, PA.

    Organ quality estimation is critical in allocation and organ acceptance in renal transplantation. Standard methods determine the likelihood of an outcome of interest utilizing Cox…
  • 2018 American Transplant Congress

    High GFR in Kidney Donors is Associated with Increased Risk of Proteinuria and Diabetes

    D. Keys, S. Riad, V. Vakil, S. Jackson, D. Berglund, A. Matas.

    University of Minnesota, Minneapolis, MN.

    Background: Measured glomerular filtration rate (GFR) has been part of the donor evaluation to rule out low GFR donors from taking undue risk for ESRD.…
  • 2018 American Transplant Congress

    Steroid Avoidance in Renal Transplant Patients Treated with Everolimus and Low-Exposure Tacrolimus

    T. Sandes-Freitas,1,2 M. Sales,1 J. Oliveira,1 M. Oliveira,1 G. Dantas,2 C. Girão,1 R. Esmeraldo.1

    1Hospital Geral de Fortaleza, Fortaleza, Ceara, Brazil; 2Universidade Federal do Ceara, Fortaleza, Ceara, Brazil.

    Background: Previous studies reported efficacy and safety of steroid-free regimens after kidney transplant (KT). However, there is no robust evidence on this strategy in patients…
  • 2018 American Transplant Congress

    Presence of Chronic Vascular Lesions on Allograft Biopsy is Associated with Greater Improvement in Renal Function after Conversion from Tacrolimus to Belatacept

    M. Perez-Saez,1,2 B. Yu,1 A. Uffing,1 N. Murakami,1 J. Azzi,1 S. El Haji,3 S. Gabardi,3 L. Riella.1

    1Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; 2Servicio de Nefrologia, Hospital del Mar, Barcelona, Spain; 3Pharmacy Services, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

    Background: Conversion from tacrolimus to belatacept has been shown to be beneficial for an increasing number of kidney transplant (KT) patients. However, predicting factors for…
  • 2018 American Transplant Congress

    Long-Term Outcomes of a Steroid-Free, Belatacept-Based Immunosuppressive Regimen Plus Sirolimus Using Alentuzumab Induction in Renal Transplantation

    A. Guasch,1 A. Ghali,1 S. Mead,1 A. Mehta,1 H. Xu,2 A. Kirk.2

    1Emory Transplant Center, Emory University, Atlanta, GA; 2Dept of Surgery, Duke University, Durham, NC.

    The toxicities of CNIs and steroids have a negative impact on kidney transplantation. Belatacept is a safe, non-nephrotoxic alternative to CNIs, that may lead to…
  • 2018 American Transplant Congress

    Taking Specific Steps to Pursue Living Donor Kidney Transplant is Associated with Greater Odds of Having a Potential Living Donor Identified

    A. Ali,1 D. Toews,1 N. Singh,1 A. Ayub,1 C. Richardson,1 S. Dano,1 D. Wong,1 J. Peipert,2 A. Waterman,2 M. Novak,1 I. Mucsi.1

    1University Health Network, Toronto, ON, Canada; 2David Geffen School of Medicine, UCLA, Los Angeles, CA.

    Background:When planning interventions to increase living donor kidney transplant (LDKT), it is important to understand what actions can patients take that are associated with an…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 211
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences